Metabolism, Metabolomics, and Nutritional Support of Patients with Sepsis.

Joshua A Englert, Angela J Rogers

Journal: Clinics in chest medicine 2017;37(2):321-31

PMID: 27229648

Abstract

Sepsis is characterized by profound changes in systemic and cellular metabolism that disrupt normal metabolic homeostasis. These metabolic changes can serve as biomarkers for disease severity. Lactate, a metabolite of anaerobic metabolism, is the most widely used ICU biomarker and it is incorporated into multiple management algorithms. Technological advances now make broader metabolic profiling possible, with early studies identifying metabolic changes associated with sepsis mortality. Finally, given the marked changes in metabolism in sepsis and the association of worse prognosis in patients with severe metabolic derangements, we summarize the seminal trials conducted to optimize nutrition in the ICU.

Copyright © 2016 Elsevier Inc. All rights reserved.

Address: Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The Ohio State University Wexner Medical Center, 473 West 12th Avenue, Columbus, OH 43210, USA.; Division of Pulmonary and Critical Care Medicine, Stanford University, 300 Pasteur Drive, H3143, Stanford, CA 94305-5236, USA. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.